Mohammed Haneefa Nizamudeen Shares of up-and-coming ADC player ImmunoGen (NASDAQ:IMGN) are down 11% over the past 5 years. Despite achieving FDA approval for lead drug candidate mirvetuximab (Elahere) recently, shares have lost a third of […]
cagkansayin Author’s note: This article was released to CEF/ETF Income Laboratory members on November 15th, 2022. The Vanguard Long-Term Corporate Bond Index ETF (NASDAQ:VCLT) is a long-term, investment-grade, corporate bond index ETF. VCLT’s 4.3% dividend […]
peshkov This article was published on Dividend Kings on Monday, Nov. 28. 2022 has been one heck of a wild ride for investors, and not just in the stock market. This is the first year […]
© Copyright 2020-2023 Forex.ca
Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.